This cluster is too small to warrant a trade. The Maduck sale is a routine option-exercise cash-out, and Mahoney's $48K sale is negligible. Monitor for any material insider buying or a larger cluster (>0.5% of market cap) before reading bearish signals. The strong historical positive drift on CORT reports suggests the stock has been resilient to insider selling patterns.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 28 $113.88entry
- T+1 · 3mo ago −0.47%α −0.17% · $113.35
- T+5 · 2mo ago −1.98%α −2.09% · $111.62
- T+20 · 7w ago +1.54%α +2.02% · $115.63
- T+55 · todayOpen
- T+60 · in 7d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Corcept Therapeutics insiders sold a total of ~$788K in shares over a week, with the bulk ($740K) from Sean Maduck (See Remarks) on August 25 following a derivative exercise. Director David Mahoney sold a small $48K lot on August 18. The total value is just 0.006% of Corcept's $12.6B market cap, a trivial amount that does not indicate a bearish signal. The cluster is a sell, but the dollar amount is immaterial relative to company size, and the Maduck sale appears to be a routine cash-out following option exercise, not an informed bearish bet. The cross-filing actuarial verdicts show multiple AMPLIFIER combos, but none apply here because the cluster value is below the materiality threshold. The 30-day prior insider activity shows $17.3M in sells, consistent with ongoing routine diversification. No material bearish read-through.
Key Financial Metrics
Key Facts
- Two insiders sold a combined ~$788K in CORT shares over 7 days
- Sean Maduck sold ~$740K on Aug 25 after exercising options at $11.35/share
- Director David Mahoney sold $48K on Aug 18
- Total cluster value is ~0.006% of CORT's $12.6B market cap, trivial
- Prior 30-day insider activity: $17.3M in sells across 7 transactions
Financial Impact
~$788K total insider sales, representing ~0.006% of market cap
Risk Factors
- Insider selling could accelerate if the stock continues to rally
- The 30-day prior selling pattern ($17.3M) is notable but still <0.2% of market cap, not yet a red flag
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1787900602593 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20262d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20265d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202613d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202619d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20265w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers